Skip Standard Navigation Links
Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
peer-reviewed.gif (582 bytes)
eid_header.gif (2942 bytes)
 EID Home | Ahead of Print | Past Issues | EID Search | Contact Us | Announcements | Suggested Citation | Submit Manuscript

Volume 11, Number 7, July 2005

New Lymphogranuloma Venereum Chlamydia trachomatis Variant, Amsterdam

Joke Spaargaren,* Han S.A. Fennema,* Servaas A. Morré,† Henry J.C. de Vries,‡ and Roel A. Coutinho§
*Municipal Health Service, Amsterdam, the Netherlands; †VU University Medical Center, Amsterdam, the Netherlands; ‡Academic Medical Center, Amsterdam, the Netherlands; and §National Institute of Public Health and Environment, Bilthoven, the Netherlands

 
 
Figure.
  Back to article
 

Figure. Schematic representation of the Chlamydia trachomatis ompA gene. In detail, variable segment 2 (VS-2): nucleotide and amino acid (aa) sequence comparison of the prototypes L1, L2, L2´, L2a, and L3 and the newly identified lymphogranuloma venereum (LVG) strain, which we designated L2b. Conserved nucleotides in VS-2 for all LGV strains are shown in red. The nucleotide substitutions in L2b as compared to all LGV strains is indicated by arrows. All aa encoded by the substitution combinations are indicated. CS = constant segment; omp = outer membrane protein.

 

EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z

This page last reviewed June 15, 2005

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention